Vanderbilt University Medical Center: Study Identifies Key Regulator of Melanoma Development
June 30, 2023
June 30, 2023
NASHVILLE, Tennessee, June 30 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth -- a discovery that supports the continued development of drugs that inhibit the receptor's activity.
Ann Richmond, PhD, Ingram Professor of Cancer Biology and professor of Pharmacology, is internationally known for her . . .
Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth -- a discovery that supports the continued development of drugs that inhibit the receptor's activity.
Ann Richmond, PhD, Ingram Professor of Cancer Biology and professor of Pharmacology, is internationally known for her . . .